Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Anticoagulation for atrial fibrillation in patients with active cancer: Reply to the ‘Letter to the Editor’ from Dr. Sorigue et al. — Maria Cristina Vedovati (2019) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Anticoagulation for atrial fibrillation in patients with active cancer: Reply to the ‘Letter to the Editor’ from Dr. Sorigue et al.
Shared by
Giancarlo Agnelli
University of Perugia
Anticoagulation for atrial fibrillation in patients with active cancer: Reply to the ‘Letter to the Editor’ from Dr. Sorigue et al.
Letter
2019
en
Authors
+1 more
MV
Maria Cristina Vedovati
MG
Michela Giustozzi
Giancarlo Agnelli
University Of Perugia
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2025
Reply to the letter to editor: ‘Oral anticoagulation in atrial fibrillation and heart failure: bridging trials, registry data, guidelines, and real-world practice’ by Lenormand et al.
Bernadette Corica
,
Giulio Francesco Romiti
,
Professor Gregory Lip
Article
2008
Reply to Dr. Green et al.
Khaled Ezzedine
,
Denis Malvy
,
Serge Briançon
,
Serge Hercberg
Letter
2018
Response by Chao et al to Letter Regarding Article, “Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study”
Tze‐Fan Chao
,
Professor Gregory Lip
,
Shih‐Ann Chen
Article
2006
Reply to the comment by Dr. Hasibeder et al.
Jacques Créteur
,
Jean Louis Vincent
Letter
2020
Response by Lee et al to Letter Regarding Article, “Oral Anticoagulation in Asian Patients With Atrial Fibrillation and a History of Intracranial Hemorrhage”
So-Ryoung Lee
,
Eue-Keun Choi
,
Professor Gregory Lip
.jpg){kind=small}
Discussion(0)
No comments yet. Be the first to comment.